Statements of Cash Flows - USD ($)		12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net loss	$ (1,940)	$ (1,661,915)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on Trust Account		(75,817)
Change in fair value of warrant liabilities		(1,771,678)
Excess of fair value over cash received for private placement warrants		355,999
Offering costs allocated to warrant issuance		844,080
Changes in current assets and current liabilities:
Prepaid assets		(345,259)
Accounts payable	1,940	1,168,048
Net cash used in operating activities		(1,486,542)
Cash Flows from Investing Activities:
Investment of cash in Trust Account		(345,000,000)
Net cash used in investing activities		(345,000,000)
Cash Flows from Financing Activities:
Proceeds from Initial Public Offering, net of underwriting discount		338,100,000
Proceeds from issuance of Private Placement Warrants		8,900,000
Proceeds from issuance of promissory notes to related party		444,990
Cash received for share receivable		25,000
Payment of promissory notes to related party		(94,990)
Payment of offering costs		(575,076)
Net cash provided by financing activities		346,799,924
Net Change in Cash		313,382
Cash – Beginning
Cash – Ending		313,382
Non-cash investing and financing activities:
Initial value of Class A common stock subject to possible redemption		345,000,000
Initial value of warrant liabilities		24,205,999
Accretion for Class A common stock subject to possible redemption		75,817
Deferred underwriting discount payable charged to additional paid-in capital		12,075,000
Increase in stock subscription receivable for issuance of Class B common stock	25,000
Accrued deferred offering costs	$ 28,860